NUBEQA (Darolutamide) Patient Assistance Program

Don’t let the high cost of advanced prostate cancer therapy stand between you and the treatment you need. We help eligible patients access Nubeqa (darolutamide) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.

HIPAA Compliant

BBB Accredited

Secure Website

Key ​Takeaways:

What Is Nubeqa Prescription Assistance Program?

The Nubeqa Prescription Assistance Program is a manufacturer-sponsored initiative that provides Nubeqa at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for uninsured and underinsured individuals, as well as Medicare Part D beneficiaries who cannot afford their specialty oncology therapy.

Navigating the program on your own, however, means dealing with eligibility verification, oncology-team coordination, complex documentation, specialty pharmacy logistics, and annual re-enrollment deadlines — all while managing advanced prostate cancer treatment that depends on uninterrupted therapy.

AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification — so you focus on your treatment, not paperwork.

Pharmacy Price Comparison

Pharmacy(With Coupon)PrIce (30-Day)*You Save W/ Us
Walgreens

~$17,800.00

Save ~$17,730/mo

CVS Pharmacy

~$17,500.00

Save ~$17,430/mo

Walmart

~$17,200.00

Save ~$17,130/mo

Costco

~$16,800.00

Save ~$16,730/mo

GoodRx Best Price

~$16,500.00

Save ~$16,430/mo

*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.

Our Pricing:

$69.95 Per month

1 Medications

$79.95 Per Month

2 Medications

$89.95 Per Month

3 Medications

$99.95 Per Month

4+ Medications

Why choose us For Your Nubeqa Prescription Program?

The Patient Assistance Program is free to apply for and provides medication at no medication cost if approved. But the process involves detailed applications, oncology-team coordination, specialty pharmacy logistics, and ongoing renewal management — particularly complex for a six-figure specialty oncology therapy. Our $69.95/month service covers full advocacy: applications, doctor coordination, documentation, specialty refill management, and annual re-enrollment — so you focus on your treatment, not paperwork.

Enroll

Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.

We Advocate

Our specialists help gather documentation, complete applications, and coordinate with program providers.

Receive Medication

Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.

Discount Coupons vs. Patient Assistance Programs

Many patients try discount cards first. Here’s why the Patient Assistance Program through Afford My Prescriptions is the better longterm solution:  

Limitations of Coupons

  • Prices fluctuate — savings aren’t guaranteed month-to-month
  • Copay accumulators may prevent savings from counting toward deductible
  • Cards expire and require constant renewal
  • Subject to strict monthly or annual maximum savings caps
  • Can’t be used with Medicare, Medicaid, or government insurance

Advantages of PAP Through Us

  • Fixed $69.95/month — never changes regardless of retail price
  • No expiration — continuous access as long as you qualify
  • Medication supplied directly from the manufacturer
  • We manage all paperwork, refills, and renewals
  • If denied, we explore alternative savings on your behalf

DO YOU QUALIFY?

Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Nubeqa assistance.

Understanding Noritate:

Nubeqa (darolutamide) is an oral prescription specialty oncology medication used to treat advanced prostate cancer in adult men. It belongs to a newer class of medications called androgen receptor inhibitors and is taken in combination with ongoing hormone therapy that lowers testosterone. It is FDA-approved for non-metastatic castration-resistant prostate cancer (nmCRPC) and for metastatic castration-sensitive prostate cancer (mCSPC) when used with docetaxel.


How It Works:

Most prostate cancer cells grow in response to male hormones called androgens, of which testosterone is the most important. Hormone therapy used in prostate cancer lowers testosterone production or blocks how testosterone reaches the cancer cell. Nubeqa belongs to a newer class of medications called androgen receptor inhibitors, which act inside the cancer cell rather than at the level of testosterone production.

Specifically, Nubeqa attaches to the androgen receptor — the protein inside prostate cancer cells that picks up the testosterone signal — and blocks the receptor from doing its job. With the receptor blocked, the cancer cell cannot read the testosterone signal that would otherwise tell it to grow and divide. The result is slower disease progression and, in many patients, a longer period of stable disease. Because Nubeqa works at the receptor, it is given alongside hormone therapy that continues to lower testosterone levels in the body.


Form and Use:

The standard dose is 600 mg by mouth twice daily, taken as two 300 mg tablets at each dose, with food. For patients with severe kidney impairment who are not on dialysis, the prescriber may use a reduced dose. Your oncology team will tell you the specific schedule that fits your treatment plan and will adjust dosing if needed for side effects or kidney or liver function changes.

Generic Availability:

There is no FDA-approved generic version of Nubeqa available in the U.S. as of 2026. Nubeqa is a relatively recently approved oncology medication, and the patent and exclusivity protections that prevent generic entry are expected to remain in force for several years. Until a generic equivalent becomes available, patients who need Nubeqa will continue to face brand-only pricing. Other treatment paths exist for prostate cancer at this stage of disease, including alternative androgen receptor inhibitors and different combinations with chemotherapy — those choices belong with your oncology team, who will weigh efficacy, side effects, and your treatment history


Warnings:

Nubeqa is taken alongside ongoing hormone therapy that lowers testosterone (such as a leuprolide-type injection or, in some cases, surgical orchiectomy) — it is not a replacement for that therapy. Take Nubeqa exactly as prescribed and do not stop the medication without talking to your prescriber. Common side effects include fatigue, pain in extremities, and rash; possible serious risks include ischemic heart disease and seizures. Tell your oncology team about any heart conditions, history of seizures, kidney or liver problems, and all medications you take, since drug interactions can affect Nubeqa levels.

FAQ (Frequently Asked Questions)

How Much Does Nubeqa Cost Without Insurance?

The average retail price is approximately $18,067 per month, with prices commonly ranging $11,500–$18,000 depending on pharmacy. Even with the best GoodRx coupons, prices remain $16,500–$19,000 — coupon discounts are small relative to the underlying price. Through AffordMyPrescriptions, qualifying patients receive Nubeqa at no medication cost — our $69.95 monthly fee covers full advocacy and program management.

We are not a pharmacy — we are an advocacy service that enrolls eligible patients into the manufacturer’s free or discounted Nubeqa Patient Assistance Program. Our $69.95/month fee covers the work of completing applications, coordinating with your oncology team, handling documentation, managing specialty refill cycles, and processing annual re-certifications. The medication itself comes through the assistance program.

No. There is no generic or biosimilar version of Nubeqa available in the U.S. as of 2026, and patent protections are expected to remain in force for several years. Other androgen receptor inhibitors used in prostate cancer may have different pricing or different patient-assistance options — whether any is a clinical fit is a decision for your oncology team.

Most enrolled patients receive their first Nubeqa shipment within two to four weeks of completing the documentation. Timing depends on how quickly your oncology team returns the required forms and the program processes your application. Eligible patients new to Nubeqa may also qualify for a 1-month free trial supply to bridge the application period.

Take Control of Your Medication Costs

If you are struggling with the high cost of Nubeqa, our team may be able to help you access assistance programs designed to make advanced prostate cancer therapy affordable. Check your eligibility today and take the first step toward predictable, sustainable treatment.

Submit Enrollment Form

Start free by filling out a simple online form.

Receive Welcome Call

Our specialist will contact you for a quick welcome call.

We Manage The Process

Our team handles everything, so you can focus on your health.

Receive Welcome Call

We Manage The Process